Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

SEHK:836
SEHK:836Renewable Energy

Does Recent Output Volatility Test the Renewable Growth Strategy at China Resources Power (SEHK:836)?

China Resources Power Holdings recently reported its production results for September 2025, showing an 8% year-on-year decline in total net generation led by decreases in thermal and wind outputs, partly offset by strong photovoltaic growth. While September saw weaker generation mainly due to weather and maintenance, the company achieved solid nine-month gains driven by increased wind and solar output, highlighting resilience in renewable expansion. We’ll explore how ongoing renewable growth...
NYSE:REXR
NYSE:REXRIndustrial REITs

Rexford Industrial Realty (REXR) Net Margin Outpaces Expectations, Raising Questions Over One-Off Gains

Rexford Industrial Realty (REXR) reported net profit margins of 32.9%, up from 29.3% last year, highlighting robust profitability. While the company’s earnings have grown at an impressive 29.3% per year over the past five years, growth cooled to 23.8% in the most recent year. Future projections indicate a 1.6% annual earnings decline and 5.1% revenue growth, which lags behind the broader US market. Results were buoyed by an $80.1 million one-off gain, and the shares currently trade at $43.41,...
NYSEAM:ACU
NYSEAM:ACUMedical Equipment

Acme United (ACU): Margin Decline to 5.3% Challenges Bull Narratives on Profit Quality

Acme United (ACU) reported a net profit margin of 5.3%, marking a decline from last year’s 10.1%. Negative earnings growth over the past year contrasts with its five-year average annual earnings increase of 9.4%. With revenue forecast to rise just 4.8% per year and earnings expected to fall 15.9% annually over the next three years, investors are scrutinizing the company’s weaker margins and muted prospects. The P/E ratio stands at 13.9x and the share price is $37.75, both below industry and...
NasdaqGS:FUNC
NasdaqGS:FUNCBanks

First United (FUNC) Net Margins Surge to 29.8%, Reinforcing Bullish Value Narrative

First United (FUNC) reported standout earnings growth of 54.4% over the past year, far outpacing its 5-year average of 5.3% per year. Net profit margins reached 29.8%, rising from 22.7% in the prior year, while shares are currently trading at $36.98, well below an estimated fair value of $68.47. With only one minor risk flagged and multiple rewards highlighted, including high-quality past earnings, expanding profit and revenue, and a strong value profile, the latest results point to improved...
NYSEAM:CATX
NYSEAM:CATXBiotechs

Perspective Therapeutics (CATX): Assessing Valuation After ESMO Data Release and Sharp Share Price Drop

Perspective Therapeutics revealed updated interim results from its Phase 1/2a trial of [212Pb]VMT-alpha-NET at ESMO Congress 2025, which sparked a sharp drop in the company’s share price as investors digested the latest efficacy signals. See our latest analysis for Perspective Therapeutics. This latest clinical trial update comes after a challenging year for Perspective Therapeutics. Following a brief rally in anticipation of new data, the 1-day share price return slipped by 2.5%, and the...
XTRA:GXI
XTRA:GXILife Sciences

Should FDA Approval of Lasix ONYU Prompt a Closer Look at Gerresheimer’s (XTRA:GXI) Growth Path?

On October 13, 2025, SQ Innovation received FDA approval for Lasix ONYU, a combination product featuring Gerresheimer’s proprietary on-body infusor for at-home subcutaneous drug delivery in select congestive heart failure patients. This milestone showcases Gerresheimer’s technological capabilities in advanced drug delivery devices and highlights its growing position as a full-service partner to pharmaceutical companies embracing home-based care. Next, we’ll explore how the FDA-backed rollout...